Skip to main content
Joel Gore, MD, Cardiology, Worcester, MA

JoelMGoreMD

Cardiology Worcester, MA

Adult Congenital Heart Disease, Interventional Cardiology

Professor, Medicine, University Massachusetts Medical School

Dr. Gore is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Gore's full profile

Already have an account?

  • Office

    55 Lake Ave N
    Department of Cardiovascular Medicine
    Worcester, MA 01655
    Phone+1 774-441-6500
    Fax+1 774-441-7657

Education & Training

  • UMass Chan Medical School
    UMass Chan Medical SchoolFellowship, Cardiovascular Disease, 1980 - 1982
  • UMass Chan Medical School
    UMass Chan Medical SchoolResidency, Internal Medicine, 1977 - 1980
  • University of Calgary Faculty of Medicine
    University of Calgary Faculty of MedicineClass of 1977

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1978 - 2025
  • CT State Medical License
    CT State Medical License 2004 - 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
  • Fellow (FACP) American College of Physicians, 2007
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Clinical Investigations Twenty-Five Year Trends (1986-2011) in Hospital Incidence and Case-Fatality Rates of Ventricular Tachycardia and Ventricular Fibrillation Compl...  
    Catarina I Kiefe, Chad E Darling, Robert J Goldberg, Joel M Gore, ScienceDirect
  • Hyperglycemia and Risk of Ventricular Tachycardia Among Patients Hospitalized with Acute Myocardial Infarction  
    Catarina I Kiefe, Joel M Gore, Robert J Goldberg, Chad E Darling, BioMed Central

Press Mentions

  • Rivaroxaban Approved to Prevent CV Events in Patients with CAD or PAD
    Rivaroxaban Approved to Prevent CV Events in Patients with CAD or PADOctober 15th, 2018
  • Cardiogenic Shock Remains a Deadly Complication of Acute MI No Matter When It Develops
    Cardiogenic Shock Remains a Deadly Complication of Acute MI No Matter When It DevelopsJune 9th, 2017
  • Statin-Intolerant Patients Face Higher Risk for Recurrent MI
    Statin-Intolerant Patients Face Higher Risk for Recurrent MIMarch 14th, 2017
  • Join now to see all

Professional Memberships